Urology News and Research

Latest Urology News and Research

Mayo Clinic achieves Honor Roll status in U.S. News and World Report's top hospitals ranking

Mayo Clinic has achieved the highest honor in U.S. News and World Report's ranking of top hospitals. Mayo Clinic earned more number one rankings than any other provider, ranking number one or number two in 11 of the 12 specialties based on reputation, services and volumes, safety and clinical outcomes.

16 Jul 2014

Game theory identifies ideal time to disrupt metastatic cancer cell cooperation

Cancer's no game, but researchers at Johns Hopkins are borrowing ideas from evolutionary game theory to learn how cells cooperate within a tumor to gather energy.

16 Jul 2014

Mount Sinai Hospital earns top rankings on the U.S. News & World Report's Best Hospitals Honor Roll

By earning "top rankings" in six out of 16 medical specialties, The Mount Sinai Hospital achieved "Honor Roll" status in this year's U.S. News & World Report "Best Hospitals" guidebook.

16 Jul 2014

Memorial Sloan Kettering ranked number one cancer hospital in the U.S.

Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the revered list 25 years ago, MSK has held either the first or second spot each year.

16 Jul 2014

Cedars-Sinai named to Honor Roll in America's Best Hospitals by U.S. News & World Report

With 12 medical specialties rated among the finest in the nation, Cedars-Sinai has been named to the Honor Roll in the 2014-15 issue of America's Best Hospitals by U.S. News & World Report.

16 Jul 2014

Prostate cancer more likely to be aggressive in younger men

The number of younger men diagnosed with prostate cancer has increased nearly 6-fold in the last 20 years, and the disease is more likely to be aggressive in these younger men, according to a new analysis from researchers at the University of Michigan Comprehensive Cancer Center.

16 Jul 2014

LUTS questionnaire validated in Japanese population

The Core Lower Urinary Symptom Score questionnaire has been validated for use in Japanese patients and may be useful as a screening tool in both clinical or research settings, researchers report.

15 Jul 2014

Urge incontinence therapy may relieve stress incontinence

Anticholinergic medication appears to be effective as a treatment for stress and mixed urinary incontinence, results of a small clinical trial indicate.

15 Jul 2014

Nocturia affects one in three premenopausal women

Nocturia affects around one-third of women of reproductive age, a survey has found, highlighting that the condition is not confined to elderly individuals.

15 Jul 2014

New research explores why active surveillance underused in patients with prostate cancer

New research from The University of Texas MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in whether older men with low-risk prostate cancer receive treatment for their disease, and if so, the type of treatment they receive as a result.

15 Jul 2014

UH Case Medical Center named one of nation's top hospitals

University Hospitals Case Medical Center has once again been named one of the nation's top hospitals, according to U.S. News & World Report's annual Best Hospitals rankings. UH Case Medical Center was ranked in all 12 methodology-ranked specialties for the third year in a row and in the Top 20 in four specialties - Cancer, Gastroenterology, Ear, Nose & Throat, and Orthopaedics.

15 Jul 2014

NAFC updates Male Stress Urinary Incontinence content

The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.

11 Jul 2014

Study examines whether men who ride have higher risk of erectile dysfunction, infertility, prostate cancer

Cycling is a popular activity that offers clear health benefits, but there is an ongoing controversy about whether men who ride have a higher risk of urogenital disorders such as erectile dysfunction, infertility, or prostate cancer.

8 Jul 2014

Protein may predict outcome of targeted mccRCC therapy

Levels of carbonic anhydrase 9 increase with the use of vascular endothelial growth factor-targeted therapy for metastatic clear-cell renal cancer, and high expression of this protein is associated with increased survival, show study results reported in European Urology.

3 Jul 2014

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.

2 Jul 2014

LUTS highly prevalent in western Turkish population

Researchers have published the first-ever estimate of the prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in the population of western Turkey.

30 Jun 2014

Metabolic syndrome components may influence LUTS/BPH

Abdominal aortic calcification and visceral fat obesity each seem to influence lower urinary tract symptoms in men with benign prostatic hyperplasia, study findings suggest.

30 Jun 2014

Actavis seeks FDA ANDA approval for generic Zubsolv, confirms patent challenge

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.

30 Jun 2014

FDA grants Thermedx 510(k) clearance for optional fluid warming in arthroscopic, hysteroscopic procedures

Thermedx, LLC, an innovative designer and manufacturer of "smart" surgical irrigation products, received FDA 510(k) clearance for optional fluid warming in arthroscopic and hysteroscopic procedures.

30 Jun 2014

Chesapeake Urology presents $114,248 to Urology Care Foundation for prostate cancer research

In ongoing support of prostate cancer research, Sanford Siegel, M.D., President and CEO of Chesapeake Urology Associates, presented the Urology Care Foundation with a check for $114,248 in support of its prostate cancer research efforts.

28 Jun 2014